VaxGen, Raven Bio terminate merger agreement
See our story about these two South San Francisco, Calif., biotechs in today’s daily briefing at VentureBeat LifeScience.
Next Story: Mobile game software company Mobile Digital Media gets $2M recapitalization
Previous Story: Paramount moves into video games
About the Author, David P. Hamilton
David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.